TCM
ECYT

Tekla Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Tekla Capital Management’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-41,980
Closed -$746K – 219
2018
Q3 		$746K Buy
+41,980
New +$721K 0.03% 188
2013
Q3 		– Sell
-60,200
Closed -$790K – 66
2013
Q2 		$790K Buy
+60,200
New +$812K 0.11% 57

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return